These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8282533)

  • 21. Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.
    Srinivasan J; Leventer RJ; Kornberg AJ; Dahl HH; Ryan MM
    Pediatr Neurol; 2008 Apr; 38(4):293-5. PubMed ID: 18358413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth disease associated with "essential tremor": Report of 7 cases and a review of the literature.
    Salisachs P
    J Neurol Sci; 1976 May; 28(1):17-40. PubMed ID: 932772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanisms.
    Warner LE; Garcia CA; Lupski JR
    Annu Rev Med; 1999; 50():263-75. PubMed ID: 10073277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A.
    Koc F; Guzel AI
    J Dermatol; 2009 May; 36(5):306-11. PubMed ID: 19383003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An acute onset extrapyramidal, pyramidal, and cerebellar syndrome with eye movement dysfunction].
    Lippi A; Castelnovo G; Colombier L; Renard D
    Rev Neurol (Paris); 2015 Dec; 171(12):898-9. PubMed ID: 26318889
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical reasoning: a young man with reversible paralysis, cerebral white matter lesions, and peripheral neuropathy.
    Zhong L; Yan K; Liu C; Xue J; Wu L; Yin F
    Neurology; 2012 Aug; 79(8):e70-2. PubMed ID: 22915180
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic basis of peripheral neuropathies.
    Valentijn LJ; Baas F
    Prog Brain Res; 1998; 117():249-64. PubMed ID: 9932413
    [No Abstract]   [Full Text] [Related]  

  • 29. Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse.
    Sidoli M; Musner N; Silvestri N; Ungaro D; D'Antonio M; Cavener DR; Feltri ML; Wrabetz L
    J Neurosci; 2016 Nov; 36(44):11350-11361. PubMed ID: 27807175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome.
    Hogan-Dann CM; Fellmeth WG; McGuire SA; Kiley VA
    JAMA; 1984 Nov 23-30; 252(20):2862-3. PubMed ID: 6092732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
    Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
    Kobsar I; Hasenpusch-Theil K; Wessig C; Müller HW; Martini R
    J Neurosci Res; 2005 Sep; 81(6):857-64. PubMed ID: 16041800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoclonic seizures in a patient with Charcot-Marie-tooth disease.
    Piantino JA; Torres A
    Pediatr Neurol; 2007 Feb; 36(2):118-20. PubMed ID: 17275665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
    Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
    Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice.
    Previtali SC; Quattrini A; Fasolini M; Panzeri MC; Villa A; Filbin MT; Li W; Chiu SY; Messing A; Wrabetz L; Feltri ML
    J Cell Biol; 2000 Nov; 151(5):1035-46. PubMed ID: 11086005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).
    Igarashi M; Thompson EI; Rivera GK
    Med Pediatr Oncol; 1995 Aug; 25(2):113-6. PubMed ID: 7603395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
    Tranchant C; Ruh D; Warter JM
    Rev Neurol (Paris); 1994; 150(1):72-4. PubMed ID: 7801046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and management of upper extremity neuropathies in Charcot-Marie-Tooth disease.
    Brown RE; Zamboni WA; Zook EG; Russell RC
    J Hand Surg Am; 1992 May; 17(3):523-30. PubMed ID: 1319438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
    Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
    Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-hypertrophic familial neuropathy associated with intention tremor. A variety of Charcot-Marie-Tooth disease?
    Delwaide PJ; Schoenen J
    J Neurol Sci; 1976 Jan; 27(1):59-69. PubMed ID: 175133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.